Please wait while the transcript is being prepared...
0:00
My name is Hannah Polson,
and I'm Scientific Director at MediTech Media.
This is one of the medical communications agencies
which is part of the Nucleus Global network.
Today, I'm going to be talking to you about medical communications,
touching off the principles and sharing with you some of
the best practice I have acquired over the last eight years.
0:19
The first thing I'd like to do is try to answer the question,
what is medical communications?
It's not actually that easy to answer.
0:27
So the general principle of medical communications
is about getting the right information,
the right audience, throughout time, and in the right way.
So as you can imagine, there are a huge amount of variables.
So how do you get it right? Well, you get it right by asking the right questions.
0:44
So in my talk today,
I'm going to be going through who is being communicated with.
In terms with that, we'll be talking about what our audiences are,
what do they need to know,
both from the perspective of what they do in their daily job,
and what are the communication imperatives in
relation to the medical intervention we want to teach them about,
then I'm going to cover off where we get the information from.
As I'm sure you can imagine the evidence generation which is involved in launching
of therapy is huge and different information comes from different places.
Then we're going to think about how we actually then
get all this information to our audience.
So here, we're going to be talking about the types of channels we use.
Finally, I'm going to talk a little bit about why we do what we do.
So without further ado, let's ask the first question.
Who are we actually communicating with?
1:30
So as you can see here,
in medical communications, we have quite a diverse range of audiences.
1:36
Our first audience here.
We're going to look at more closely the scientific community.
The scientific community will be made up of people working all
the way from drug discovery up to real world evidence generation.
Your researcher could be a bench based person or a clinical researcher.
Some of them will be academic and some of them will have clinical experience.
Broadly speaking, they're all going to be interested in the disease background.
They'll need to know the pathology
and the molecular characteristics of the disease they work in.
They're going to be very interested in
the latest research findings as this is something themselves they will be generating.
As a very bench based researcher,
new techniques could be a huge focus, as more of a clinical based researcher,
the latest clinical and efficacy data is more likely to be your interest.
Sometimes meta analysis will be of relevance. This is
a way of comparing data from clinical trials which have differences in them.
But the ultimate goal of this audience is to build
on the existing information and to further their understanding,
and then using this further understanding to develop new medical innovations.
